Home Page
The Company
Product Portfolio
- Products
- Our Foundation
Press Releases & Events
- Press Releases
  - Recent
  - Archives
    - 2017
    - 2016
    - 2015
    - 2014
    - 2013
    - 2012
    - 2011
- Events
  - Upcoming
  - Past
Careers
- Current Listings
Contact Us

Home Page
The Company
Product Portfolio
Press Releases & Events
Careers
Contact Us

- Home Page
- The Company
- Product Portfolio
  - Products
  - Our Foundation
- Press Releases & Events
  - Press Releases
    - Recent
    - Archives
      
      2017
      
      2016
      
      2015
      
      2014
      
      2013
      
      2012
      
      2011
  - Events
    - Upcoming
    - Past
- Careers
  - Current Listings
- Contact Us

Products

FIDIA PHARMA USA INC.

In partnership with CIPHER PHARMACEUTICALS

Our Four Leading Principles:

Innovation

Quality

Internationalization

Competitiveness

Visit our
Corporate
Website

Fidia Farmaceutici S.P.A.

Fidia's Other Websites

Direct link to:
cartijoint.com
hyalgan.com
hyalogyn.com
hymovis.com
nudynus.com
triluron.com

Follow Us

Key Business Areas

Drawing on the strengths of the parent company, our product portfolio focuses primarily on therapeutic areas such as joint healthcare and women's health.

Fidia Pharma USA is focused on providing unique, innovative and reliable Hyaluronic Acid (HA)-based treatment options.

©2019 Fidia Pharma USA Inc, Florham Park, NJ
This site is intended for use by US residents only. Last Update: December 2019 FID784-12.2019

Legal Terms
Privacy Policy
Copyright

Are you sure you want to navigate away from this page?

Click OK to continue or Cancel to stay on current page.

Ok